CQW Panacea-re-brand-rev3


For the Week of November 17, 2014


How does Medicare reimburse blood-clotting factors?


Under the hospital outpatient prospective payment system (OPPS), Medicare reimburses for blood-clotting factors under the same methodology as other nonpass-through separately payable drugs and biological, which is at the average sales price (ASP) plus 6 percent. It also pays a furnishing fee.

Return to Compliance Question of the Week Index


Sign up to receive Compliance Question of the Week.

To view and archive of the Pharmacy Compliance Question fo the Week, click here